$-0.18 EPS Expected for Adamis Pharmaceuticals (ADMP); 1 Bullish Analysts Covering Credit Acceptance (CACC)

July 18, 2018 - By Catherine Smith

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Logo

Analysts expect Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) to report $-0.18 EPS on August, 13.They anticipate $0.01 EPS change or 5.26% from last quarter’s $-0.19 EPS. After having $-0.23 EPS previously, Adamis Pharmaceuticals Corporation’s analysts see -21.74% EPS growth. The stock decreased 3.25% or $0.125 during the last trading session, reaching $3.725. About 333,876 shares traded. Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) has risen 14.47% since July 18, 2017 and is uptrending. It has outperformed by 1.90% the S&P500. Some Historical ADMP News: 08/03/2018 – Adamis Pharmaceuticals Announces Publication of a New Human Factors Study Comparing Its Symjepi™ Epinephrine Prefilled Syringe to the Market Leading Product in the Annals of Allergy, Asthma and lmmunology; 08/03/2018 – Adamis Pharmaceuticals Announces Publication of a New Human Factors Study Comparing Its Symjepi™ Epinephrine Prefilled Syring; 06/03/2018 – Adamis Pharmaceuticals Provides Update on Data Presented at the American Academy of Allergy, Asthma and lmmunology (AAAAI) Joint Congress With the World Allergy Organization; 22/04/2018 – DJ Adamis Pharmaceuticals Corporation, Inst Holders, 1Q 2018 (ADMP); 06/03/2018 ADAMIS PHARMACEUTICALS PROVIDES UPDATE ON DATA PRESENTED AT THE AMERICAN ACADEMY OF ALLERGY, ASTHMA AND IMMUNOLOGY (AAAAI) JOINT CONGRESS WITH THE WORLD ALLERGY ORGANIZATION; 15/03/2018 – Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update; 06/03/2018 – Adamis Pharmaceuticals Provides Update on Data Presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) Join

Among 3 analysts covering Credit Acceptance Corp (NASDAQ:CACC), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Credit Acceptance Corp had 3 analyst reports since January 30, 2018 according to SRatingsIntel. The rating was maintained by BMO Capital Markets with “Hold” on Wednesday, January 31. The firm earned “Hold” rating on Tuesday, January 30 by Susquehanna. The stock has “Buy” rating by Oppenheimer on Thursday, April 12. See Credit Acceptance Corporation (NASDAQ:CACC) latest ratings:

12/04/2018 Broker: Oppenheimer Rating: Buy New Target: $365.0000 Maintain
31/01/2018 Broker: BMO Capital Markets Rating: Hold New Target: $295.0 Maintain
30/01/2018 Broker: Susquehanna Rating: Hold New Target: $358.0 Maintain

Since February 5, 2018, it had 0 insider buys, and 5 selling transactions for $2.85 million activity. The insider Booth Kenneth sold $669,000. The insider BUSK DOUGLAS W sold $270,100. Soave John S. had sold 2,500 shares worth $842,525.

Investors sentiment decreased to 0.86 in 2018 Q1. Its down 0.18, from 1.04 in 2017Q4. It fall, as 32 investors sold Credit Acceptance Corporation shares while 55 reduced holdings. 29 funds opened positions while 46 raised stakes. 11.67 million shares or 9.12% less from 12.84 million shares in 2017Q4 were reported. Arrowstreet Cap Limited Partnership, Massachusetts-based fund reported 24,590 shares. Advisory Services Limited Com reported 0.02% of its portfolio in Credit Acceptance Corporation (NASDAQ:CACC). Price T Rowe Associates Inc Md holds 4,362 shares. Wellington Grp Llp holds 680,105 shares. Com Of Toledo Na Oh holds 0.07% or 806 shares. 4,273 were reported by Pub Employees Retirement Systems Of Ohio. Teachers Retirement Sys Of The State Of Kentucky stated it has 0.04% in Credit Acceptance Corporation (NASDAQ:CACC). State Street Corporation stated it has 137,681 shares or 0% of all its holdings. Blair William Company Il reported 0.03% stake. Blackrock owns 488,362 shares or 0.01% of their US portfolio. 1,954 are owned by Principal Group Inc Inc. Voya Investment Mngmt Ltd Com invested 0% of its portfolio in Credit Acceptance Corporation (NASDAQ:CACC). Aqr Capital Management Limited Liability Co reported 36,392 shares or 0.01% of all its holdings. Ontario – Canada-based Royal Bankshares Of Canada has invested 0% in Credit Acceptance Corporation (NASDAQ:CACC). Swiss National Bank & Trust stated it has 11,777 shares.

Another recent and important Credit Acceptance Corporation (NASDAQ:CACC) news was published by Globenewswire.com which published an article titled: “Credit Acceptance Announces Extension to $350 Million Revolving Secured Line of Credit Facility” on June 27, 2018.

Credit Acceptance Corporation provides financing programs, and related services and products to automobile dealers in the United States. The company has market cap of $7.13 billion. It advances money to dealers in exchange for the right to service the underlying consumer loans; and buys the consumer loans from the dealers and keeps various amounts collected from the consumers. It has a 14.39 P/E ratio. The firm also engages in the business of reinsuring coverage under vehicle service contracts sold to clients by dealers on vehicles financed by the company.

The stock increased 1.41% or $5.09 during the last trading session, reaching $367.09. About 123,056 shares traded or 28.31% up from the average. Credit Acceptance Corporation (NASDAQ:CACC) has risen 65.09% since July 18, 2017 and is uptrending. It has outperformed by 52.52% the S&P500. Some Historical CACC News: 24/05/2018 – Moody’s Assigns Definitive Ratings To Credit Acceptance Auto Loan Trust 2018-2; 03/05/2018 – CREDIT ACCEPTANCE 1Q CONSUMER LOAN UNIT VOL. +18.5%; 23/04/2018 – DJ Credit Acceptance Corporation, Inst Holders, 1Q 2018 (CACC); 03/05/2018 – CREDIT ACCEPTANCE 1Q ADJ EPS $6.11, EST. $6.13; 06/04/2018 – CREDIT ACCEPTANCE CORP. PRESIDENT JONES TO RETIRE ON JUNE 30; 03/04/2018 – Analysis: Positioning to Benefit within ForeScout Technologies, CommerceHub, Newtek Business Services, Credit Acceptance, Akari; 03/05/2018 – Credit Acceptance 1Q Adj EPS $6.11; 10/05/2018 – CREDIT ACCEPTANCE – ADDED NEW LENDER TO WAREHOUSE FACILITY IV & INCREASED AMOUNT OF FACILITY TO $250.0 MLN; 29/03/2018 – Credit Acceptance Named to the 2018 Best Workplaces in Financial Services & Insurance List by Great Place to Work® and FORTUNE; 18/04/2018 – Credit Acceptance Volume Jumps More Than Eight Times Average

Among 4 analysts covering Adamis Pharmaceuticals (NASDAQ:ADMP), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Adamis Pharmaceuticals had 4 analyst reports since March 23, 2018 according to SRatingsIntel. As per Monday, May 14, the company rating was maintained by Maxim Group. As per Friday, March 23, the company rating was maintained by B. Riley & Co. The rating was maintained by FBR Capital on Monday, May 14 with “Buy”.

Credit Acceptance Corporation (NASDAQ:CACC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.